Results

Total Results: over 10,000 records

Showing results for "blood pressure medications".

  1. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  2. www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  3. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  4. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  5. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  6. monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  7. healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  8. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
    January 01, 2020 - such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance).40 Optimization
  9. www.ahrq.gov/ncepcr/tools/workforce-financing/white-paper.html
    July 01, 2019 - outcomes such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, bloodpressure), or improvements in function (e.g., return to work, better school performance). 40 Optimization
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - However, within‐individual differences in the pharmacodynamic effect of these “similar” medications … If there’s no evidence of a pharmacodynamic effect of these life-saving medications, is it reasonable … Various factors, including the CYP2C19 genotype, concomitant medications, comorbidities, and other factors … The purpose of prescribing P2Y12‐inhibiting antiplatelet medications is to reduce the risk for thrombosis … As previously stated, the purpose of prescribing P2Y12‐ inhibiting antiplatelet medications is to reduce
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - However, within‐individual differences in the pharmacodynamic effect of these “similar” medications … If there’s no evidence of a pharmacodynamic effect of these life-saving medications, is it reasonable … Various factors, including the CYP2C19 genotype, concomitant medications, comorbidities, and other factors … The purpose of prescribing P2Y12‐inhibiting antiplatelet medications is to reduce the risk for thrombosis … As previously stated, the purpose of prescribing P2Y12‐ inhibiting antiplatelet medications is to reduce
  12. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/sharedba.pdf
    January 01, 2004 - informed about these services or accept them as a routine part of the medical exam (eg, screening for high bloodpressure or obesity), making lengthy and frequent discussion unnecessary.
  13. effectivehealthcare.ahrq.gov/products/disparities-quality-improvement/research-protocol
    February 22, 2012 - interest include: health outcome measures (e.g. morbidity and mortality, indirect health outcomes such as bloodpressure and HbA1c); process measures (e.g. proportion of patients treated according to clinical guidelines
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
    February 23, 2012 - interest include: health outcome measures (e.g. morbidity and mortality, indirect health outcomes such as bloodpressure and HbA1c); process measures (e.g. proportion of patients treated according to clinical guidelines
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
    February 23, 2012 - interest include: health outcome measures (e.g. morbidity and mortality, indirect health outcomes such as bloodpressure and HbA1c); process measures (e.g. proportion of patients treated according to clinical guidelines
  16. digital.ahrq.gov/sites/default/files/docs/citation/r01hs015274-carayon-final-report-2009.pdf
    January 01, 2009 - adverse drug events are more frequent in intensive care units primarily because of the volume of medications … After CPOE/EHR implementation, fewer medications were ordered on average in the AICU and the CICU. … adjusting monitoring and other equipment, transporting the patient, and obtaining and administering medications … Role of computerized physician order entry systems in facilitating medications errors.
  17. hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
    March 01, 2008 - ___APS-Def_Public.book 4 0 0 C a p i t a l B o u l e v a r d • R o c k y H i l l , C T 0 6 0 6 7 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7 D e f i n i t i o n s M a n u a l PUB 3.3.2008 APS-DRGs® ALL-PAYER SEVERITY-ADJUSTED DRG (APS-DRGS®) ASSIGNMENT FOR PUBLIC USE VERSION 24 COPYRIGHT PAGE Copyright © 2008 In…
  18. www.ahrq.gov/sites/default/files/2024-07/robins-report.pdf
    January 01, 2024 - The demonstrated benefits of fostering autonomous patient motivation include greater adherence to medications … Record - EMR) From the EMR, we collected key physiological marker variables for all patients (e.g., bloodpressure and HbA1c) within each physician’s panel.
  19. hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR-User-Guide-v2021-1.pdf
    December 01, 2020 - PRCCSR-User-Guide-v2021-1 USER GUIDE: CLINICAL CLASSIFICATIONS SOFTWARE REFINED (CCSR) FOR ICD-10-PCS PROCEDURES, v2021.1 Issued December 2020 Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP) Phone: (866) 290-HCUP (4287) Email: hcup@ahrq.gov Website: www.hcup-us…
  20. preventiveservices.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/ambulatory-surgery/sections/sustainability/training-tools/training-tools-facnotes.docx
    May 01, 2017 - AHRQ Safety Program for Ambulatory Surgery Sustainability Module Facilitator Notes SAY: This module on Sustainability helps an organization maintain and sustain a process that has worked well at a unit level. This module is meant to au…